Market Access & Market
Entry Due Diligence
Structured assessment of readiness to enter and compete in target markets. Beyond approval, focusing on pricing, reimbursement, access pathway complexity and execution capability.
BEST FOR
Launch planning and near-commercial assets
Investors evaluating late-stage opportunities
Corporate development and commercial strategy teams
WHAT WE ASSESS
Pricing feasibility and reimbursement probability
Access pathway complexity and evidence needs
Competitive positioning and value sustainability
Alignment between regulatory strategy and commercial reality
Supply capability and execution readiness
Credibility and defensibility of access assumptions
OUTPUTS
Clear view of market readiness and access risk
Practical implications for go-to-market viability
Decision support for investment/portfolio choices